About Daniel Mazzaferro
Form D filings for RheoTek Medical from 2023 to 2024 list Daniel Mazzaferro as president and director.
Daniel Mazzaferro first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Mazzaferro in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Mazzaferro works with at each company, as listed on that company's latest Form D.
RheoTek Medical LLC · Form D/A, Sep 6, 2024
SB
Scott Bartlett
Executive officer and director
SD
Steven Duddy
Executive officer and director